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Treatment of wounds represents a significant challenge at all levels of our society, in terms of cost (physical, 
emotional and financial) to patients, the economy and to the wider Australian and global communities. 
Despite this, relatively little research is directed at this hidden health problem. The Tissue Repair & 
Regeneration team at QUT is addressing this challenge using advanced biotechnological, biomaterials and 
bioengineering strategies. Our interdisciplinary team is focussed on delivering practical innovations in wound 
healing, with an emphasis on diabetic and venous ulcers, as well as burns. This ‘snapshot’ of our research 
briefly describes some of the research projects we are pursuing at QUT: interactions of growth factors with 
other components of the extracellular milieu in tissues; cellular mechanisms associated with wound healing 
and scar remediation; diagnostic and prognostic markers of healing; novel, relevant, ex vivo 3D skin 
equivalent models for pre-clinical evaluation of new wound therapeutics; and the design and production of 
“smart” bioactive wound dressings. The overall goal of our research is to generate new technologies and 
wound management interventions that keep patients healthy and obviate their need to depend upon the cost-
intensive hospital-based health care sector. 
• Structural and functional investigation of growth factor- and vitronectin-binding receptor 
cooperation in modifying cellular function.  
We have previously reported that growth factors interact with the extracellular matrix glycoprotein, 
vitronectin. Further, complexes of growth factors with vitronectin (generically referred to as VitroGro®) 
result in enhanced cell proliferation and migration leading us to evaluate this technology for: serum-free cell 
and tissue culture; surface coating of implanted prostheses; and other repair and regeneration applications. 
Using microarray and proteomic approaches we are also probing the fundamental mechanistic elements 
behind why presentation of growth factors bound to ECM proteins, such as vitronectin, enhances cell 
proliferation and migration. In addition we are currently completing pre-clinical in vivo evaluations of these 
complexes as a topical therapy for deep partial thickness burns and for diabetic ulcers. We want to 
understand how skin cells respond to the complexes in the conditions of the in vivo diabetic wound 
environment: namely in the presence of wound exudates’, high concentrations of insulin and glucose, and 
low oxygen. 
Insert Fig 1 here.  
Identifying the relationship between biochemical markers and wound healing in chronic 
venous leg ulcers treated with compression therapy.  
In allied projects we are also investigating the relationship between biochemical markers in wound fluid and 
wound healing in chronic venous leg ulcers treated with compression therapy. Again, the application of 
advanced proteomic techniques are being applied to analyse biochemical markers in sequential wound fluid 
samples collected from patients during the course of compression therapy. The aim of this project is to 
identify fluid and/or tissue indicators associated with improved or delayed healing. The identification of 
biochemical changes indicative of healing at various time points will provide basic information about the 
complex and changing wound environment and contribute to the development of models to predict healing in 
individuals and facilitate the development of new clinical management approaches.  
• Elucidating mechanisms underlying the effective use of hyperbaric oxygen as a therapy 
for wound healing  
Related to the previous project, we are also characterising the dynamic changes in wound fluid and repairing 
tissue anatomy during, and following, hyperbaric oxygen (HBO) treatment of chronic ulcers and non-healing 
wounds. These data will provide a novel window into the biochemical and cellular changes associated with 
the anecdotal benefits of hyperbaric oxygen therapy.  
Insert Fig 2 here.  
• In vitro evaluation of the potential of novel silicones for scar remediation.  
In addition to the pressing need to dissect the cellular aspects of wound healing, there is a parallel need to 
understand the process that underlies scarring. Silicone gel sheets are known to reduce the size and severity 
of scars that result from burns by an unknown mechanism. We believe that the decrease in scar tissue is due 
to the egress of specific silicone species from the sheet into the healing tissue. These silicones interact with 
fibroblasts present during granulation tissue remodelling and possibly modify the production of collagens. 
This project has identified novel characteristics of some silicones that penetrate the skin and is examining the 
effect of these novel silicone species on the synthesis and organisation of collagen by fibroblasts derived 
from normal, keloid and hypertrophic scars. In collaboration with chemists and biomaterials scientists we 
plan to exploit these silicones as an effective scar remediation therapy. This project is providing an 
opportunity to explore how nanoscale structures, such as these silicones, can impact on cellular processes.  
• Bioactive polymers for wound healing applications  
Another major aim of the QUT Tissue Repair and Regeneration team is to develop novel bioactive polymeric 
dressings for application in wound healing. One strategy is focused on releasing bioactive agents from 
provisional carriers (eg. biodegradable polymers) using cell-activated linkers such as protease sensitive 
cleavage sites.  Our second strategy is the development of two distinct polymeric delivery systems in a 
multicomponent bandage. One component will release cell-stimulatory agents and/or adjuvants as the other 
component, a responsive hydrogel, is designed to passivate wound exudates which otherwise may reduce the 
activity of the wound healing agents.  
  
 
 
Fig 1. VitroGro® stimulates the migration of keratinocytes. 
Migration of keratinocytes were assayed with, or without, vitronectin in serum-free basal media in 
Transwell™. Maximal migration is observed only when all three components of the complex are presented 
together to cells. 
(Image courtesy of Caroline Hyde) 
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Fig 2. Human skin equivalent construct for in vitro skin repair and regeneration studies. 
A. Timeline of the model construction. B. Steel rings are used to seed keratinocytes on top of the centre of 
the deepithelised dermis (DED) in a 24-well culture dish. Scale bar: 5 mm. C. Grids are used to bring the 
HSE to the air-liquid interface after the rings are removed. D. Model after 10 days culture at the air-liquid 
interface.  
Method adapted from that previously reported by Huang et al., Wound Repair Regen 2004, 12:276-287. 
(Image courtesy of Gemma Topping) 
